Dashboard
1
High Debt Company with a Debt to Equity ratio (avg) at times
- Poor long term growth as Net Sales has grown by an annual rate of 18.23% and Operating profit at -8.23% over the last 5 years
- High Debt Company with a Debt to Equity ratio (avg) at times
- The company has been able to generate a Return on Equity (avg) of 2.39% signifying low profitability per unit of shareholders funds
2
With a fall in Net Sales of -6.62%, the company declared Very Negative results in Jun 25
Total Returns (Price + Dividend) 
TimePeriod
Price Return
Dividend Return
Total Return
3 Months
0.9%
0%
0.9%
6 Months
0.15%
0%
0.15%
1 Year
36.09%
0%
36.09%
2 Years
63.44%
0%
63.44%
3 Years
-24.5%
0%
-24.5%
4 Years
0%
0%
0.0%
5 Years
0%
0%
0.0%
Zhejiang Hisun Biomaterials Co., Ltd. for the last several years.
Risk Adjusted Returns v/s 
News
No Recent News for the Company
Announcements 
No announcement available
Corporate Actions 
No corporate action available
Quality key factors 
Factor
Value
Sales Growth (5y)
18.23%
EBIT Growth (5y)
-8.23%
EBIT to Interest (avg)
5.77
Debt to EBITDA (avg)
0
Net Debt to Equity (avg)
-0.12
Sales to Capital Employed (avg)
0.43
Tax Ratio
29.79%
Dividend Payout Ratio
34.28%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
3.01%
ROE (avg)
2.39%
Valuation key factors
Factor
Value
P/E Ratio
50
Industry P/E
Price to Book Value
0.46
EV to EBIT
24.84
EV to EBITDA
6.57
EV to Capital Employed
0.43
EV to Sales
0.72
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
1.71%
ROE (Latest)
0.92%
Technicals key factors
Indicator
Weekly
Monthly
MACD
Bullish
Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Mildly Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Dow Theory
No Trend
No Trend
OBV
No Trend
No Trend
Shareholding Snapshot
No data for shareholding present.
Shareholding Compare (%holding) 
No data for shareholding present.
Quarterly Results Snapshot (Consolidated) - Sep'25 - YoY
Sep'25
Sep'24
Change(%)
Net Sales
213.20
228.30
-6.61%
Operating Profit (PBDIT) excl Other Income
5.40
29.10
-81.44%
Interest
1.90
1.40
35.71%
Exceptional Items
0.00
0.00
Consolidate Net Profit
1.70
8.40
-79.76%
Operating Profit Margin (Excl OI)
25.60%
55.00%
-2.94%
USD in Million.
Net Sales
YoY Growth in quarter ended Sep 2025 is -6.61% vs 5.45% in Sep 2024
Consolidated Net Profit
YoY Growth in quarter ended Sep 2025 is -79.76% vs -52.00% in Sep 2024
Annual Results Snapshot (Consolidated) - Dec'24
Dec'24
Dec'23
Change(%)
Net Sales
845.00
753.10
12.20%
Operating Profit (PBDIT) excl Other Income
102.40
90.80
12.78%
Interest
7.70
7.60
1.32%
Exceptional Items
0.00
0.00
Consolidate Net Profit
35.50
43.50
-18.39%
Operating Profit Margin (Excl OI)
43.70%
47.90%
-0.42%
USD in Million.
Net Sales
YoY Growth in year ended Dec 2024 is 12.20% vs 25.27% in Dec 2023
Consolidated Net Profit
YoY Growth in year ended Dec 2024 is -18.39% vs -7.45% in Dec 2023
About Zhejiang Hisun Biomaterials Co., Ltd. 
Zhejiang Hisun Biomaterials Co., Ltd.
Specialty Chemicals
No Details Available.
Company Coordinates 
No Company Details Available






